Our top resource picks

All resources

Filters
  • Clear filters
Resource Image
Legal Update

New questions referred to the Enlarged Board of Appeal at the European Patent Office on adaptation of the description – G 1/25

New referral to the Enlarged Board of Appeal on whether description adaptation is required under the EPC: G...
Resource Image
Legal Update

Patent Law & Practice at a Glance – July 2025

Read our July 2025 patent law update, including updates from the UK, the European Patent Office (EPO) and...
Resource Image
Article

Emotional Perception AI: A “Frankenstein” approach to patentability? Insights from the UK Supreme Court hearing

We examine the Emotional Perception AI (EPAI) v UKIPO appeal hearing at the UK Supreme Court about the...
Resource Image
Article

Key considerations when patenting CRISPR-based therapeutics in Europe

In this article, we set out the key aspects for innovators and applicants to consider when patenting gene...
Resource Image
Article

UK signs Riyadh Design Law Treaty – A step towards international harmonisation

The UK government has signed the Riyadh Design Law Treaty - a step towards harmonisation of design protection...
Resource Image
Article

Change in UKIPO practice following the SkyKick judgment

Following the Supreme Court’s ruling in SkyKick, the UKIPO issued guidance on 27 June 2025 in Practice Amendment...
Resource Image
Article

Innovation in the agri-tech space: How hard does the “essentially biological process” exclusion bite?

We examine why it is crucial for agri-tech companies to have awareness of the ''essentially biological process'' exclusion...
Resource Image
Article

Cultivating protection: The UK system for plant breeders’ rights

We highlight some of the key features of the current UK regime for plant variety protection, and underscore...
Resource Image
Article

Key considerations when patenting antibody-drug conjugates in Europe

Antibody-drug conjugates (ADCs) are a biotherapeutic modality typically used for the treatment of cancer.